DNAFORM Search Engine

参考文献: PNKD

Latorre A, Bhatia KP. Treatment of Paroxysmal Dyskinesia. Neurol Clin. 2020 May;38(2):433-447. doi
Drobin K, Marczyk M, Halle M, Danielsson D, Papiez A, Sangsuwan T, Bendes A, Hong MG, Qundos U, Harms-Ringdahl M, Wersll P, Polanska J, Schwenk JM, Haghdoost S. Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer. Cancers (Basel). 2020 Mar 22;12(3). pii
Dong H, Luo Y, Fan S, Yin B, Weng C, Peng B. Screening Gene Mutations in Chinese Patients With Benign Essential Blepharospasm. Front Neurol. 2020 Jan 23;10:1387. doi
Durrant TN, Moore SF, Bayliss AL, Jiang Y, Aitken EW, Wilson MC, Heesom KJ, Hers I. Identification of PtdIns(3,4)P(2) effectors in human platelets using quantitative proteomics. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158575. doi
Bago Rožanković P, Rožanković M, Romić ZČ, Bašić S. Paroxismal non-kinesigenic dyskinesia and hemidystonia associated with silent celiac disease. Clin Neurol Neurosurg. 2020 Jan;188:105586. doi
Bailey CS, Moldenhauer HJ, Park SM, Keros S, Meredith AL. KCNMA1-linked channelopathy. J Gen Physiol. 2019 Oct 7;151(10):1173-1189. doi: 10.1085/jgp.201912457. Epub 2019 Aug 19. Review. PubMed
De Gusmao CM, Silveira-Moriyama L. Paroxysmal movement disorders - practical update on diagnosis and management. Expert Rev Neurother. 2019 Sep;19(9):807-822. doi
Xu Z, Lim CK, Tan LCS, Tan EK. Paroxysmal Movement Disorders
Manso-Caldern R. Clinical Features and Treatment in the Spectrum of Paroxysmal Dyskinesias
Rebollo-Ramirez S, Larrouy-Maumus G. NaCl triggers the CRP-dependent increase of cAMP in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2019 May;116:8-16. doi
Erro R. Familial Paroxysmal Nonkinesigenic Dyskinesia. 2005 Jun 24 [updated 2019 Apr 4]. In
Zhang XJ, Xu ZY, Wu YC, Tan EK. Paroxysmal movement disorders
Zhang J, Fu Y, Chen J, Li Q, Guo H, Yang B. Genetic variant of TMBIM1 is associated with the susceptibility of colorectal cancer in the Chinese population. Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):324-329. doi: 10.1016/j.clinre.2018.10.013. Epub 2018 Nov 15. PubMed
Erro R, Bhatia KP. Unravelling of the paroxysmal dyskinesias. J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):227-234. doi
Kim SY, Lee JS, Kim WJ, Kim H, Choi SA, Lim BC, Kim KJ, Chae JH. Paroxysmal Dyskinesia in Children
Pandey S, Tomar LR, Mahadevan L. Progressive nonparoxysmal chorea and dystonia due to myofibrillogenesis regulator-1 gene mutation. Parkinsonism Relat Disord. 2019 Mar;60:186-187. doi
McGuire S, Chanchani S, Khurana DS. Paroxysmal Dyskinesias. Semin Pediatr Neurol. 2018 Apr;25:75-81. doi
Stuczyńska A, Piórkowska K, Tyra M, Żukowski K. The effect of QTL-rich region polymorphisms identified by targeted DNA-seq on pig production traits. Mol Biol Rep. 2018 Jun;45(3):361-371. doi
Silveira-Moriyama L, Kovac S, Kurian MA, Houlden H, Lees AJ, Walker MC, Roze E, Paciorkowski AR, Mink JW, Warner TT. Phenotypes, genotypes, and the management of paroxysmal movement disorders. Dev Med Child Neurol. 2018 Jun;60(6):559-565. doi
Tian WT, Huang XJ, Mao X, Liu Q, Liu XL, Zeng S, Guo XN, Shen JY, Xu YQ, Tang HD, Yin XM, Zhang M, Tang WG, Liu XR, Tang BS, Chen SD, Cao L. Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia
Wang J, Zhao W, Liu H, He H, Shao R. Myofibrillogenesis regulator 1 (MR-1)
Sun N, Nasello C, Deng L, Wang N, Zhang Y, Xu Z, Song Z, Kwan K, King RA, Pang ZP, Xing J, Heiman GA, Tischfield JA. The PNKD gene is associated with Tourette Disorder or Tic disorder in a multiplex family. Mol Psychiatry. 2018 Jun;23(6):1487-1495. doi
Set KK, Ghosh D, Huq AHM, Luat AF. Episodic Ataxia Type 1 (K-channelopathy) Manifesting as Paroxysmal Nonkinesogenic Dyskinesia
Klein C, Lohmann K, Marras C, Mnchau A. Hereditary Dystonia Overview. 2003 Oct 28 [updated 2017 Jun 22]. In
Crujeiras AB, Diaz-Lagares A, Sandoval J, Milagro FI, Navas-Carretero S, Carreira MC, Gomez A, Hervas D, Monteiro MP, Casanueva FF, Esteller M, Martinez JA. DNA methylation map in circulating leukocytes mirrors subcutaneous adipose tissue methylation pattern
Vidoni S, Harbour ME, Guerrero-Castillo S, Signes A, Ding S, Fearnley IM, Taylor RW, Tiranti V, Arnold S, Fernandez-Vizarra E, Zeviani M. MR-1S Interacts with PET100 and PET117 in Module-Based Assembly of Human Cytochrome c Oxidase. Cell Rep. 2017 Feb 14;18(7):1727-1738. doi
Lowrie M, Garosi L. Classification of involuntary movements in dogs: Paroxysmal dyskinesias. Vet J. 2017 Feb;220:65-71. doi: 10.1016/j.tvjl.2016.12.017. Epub 2017 Jan 3. Review. PubMed
Týč J, Novotná L, Peña-Diaz P, Maslov DA, Lukeš J. RSM22, mtYsxC and PNKD-like proteins are required for mitochondrial translation in Trypanosoma brucei. Mitochondrion. 2017 May;34:67-74. doi
Kolicheski AL, Johnson GS, Mhlanga-Mutangadura T, Taylor JF, Schnabel RD, Kinoshita T, Murakami Y, O'Brien DP. A homozygous PIGN missense mutation in Soft-Coated Wheaten Terriers with a canine paroxysmal dyskinesia. Neurogenetics. 2017 Jan;18(1):39-47. doi
Orlando G, Law PJ, Palin K, Tuupanen S, Gylfe A, Hnninen UA, Cajuso T, Tanskanen T, Kondelin J, Kaasinen E, Sarin AP, Kaprio J, Eriksson JG, Rissanen H, Knekt P, Pukkala E, Jousilahti P, Salomaa V, Ripatti S, Palotie A, Jrvinen H, Renkonen-Sinisalo L, Lepist A, Bhm J, Mecklin JP, Al-Tassan NA, Palles C, Martin L, Barclay E, Tenesa A, Farrington S, Timofeeva MN, Meyer BF, Wakil SM, Campbell H, Smith CG, Idziaszczyk S, Maughan TS, Kaplan R, Kerr R, Kerr D, Buchanan DD, Win AK, Hopper J, Jenkins M, Lindor NM, Newcomb PA, Gallinger S, Conti D, Schumacher F, Casey G, Taipale J, Cheadle JP, Dunlop MG, Tomlinson IP, Aaltonen LA, Houlston RS. Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease. Hum Mol Genet. 2016 Jun 1;25(11):2349-2359. Epub 2016 Mar 22. PubMed
Wang XR, Ding R, Tao TQ, Mao HM, Liu M, Xie YS, Liu XH. Myofibrillogenesis Regulator 1 Rescues Renal Ischemia/Reperfusion Injury by Recruitment of PI3K-Dependent P-AKT to Mitochondria. Shock. 2016 Nov;46(5):531-540. PubMed PMID: 27219857.
Mneret A, Roze E. Paroxysmal movement disorders
Wang HX, Li HF, Liu GL, Wen XD, Wu ZY. Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients. Chin Med J (Engl). 2016 May 5;129(9):1017-21. doi
Kumar A, Szekely A, Jabbari B. Effective Treatment of Paroxysmal Nonkinesigenic Dyskinesia With Oxcarbazepine. Clin Neuropharmacol. 2016 Jul-Aug;39(4):201-5. doi
Wang C, Xiang H, Si H, Guo D, Sun M. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14818-23. eCollection 2015. PubMed
Pettinati I, Brem J, Lee SY, McHugh PJ, Schofield CJ. The Chemical Biology of Human Metallo-β-Lactamase Fold Proteins. Trends Biochem Sci. 2016 Apr;41(4):338-355. doi
Gardiner AR, Jaffer F, Dale RC, Labrum R, Erro R, Meyer E, Xiromerisiou G, Stamelou M, Walker M, Kullmann D, Warner T, Jarman P, Hanna M, Kurian MA, Bhatia KP, Houlden H. The clinical and genetic heterogeneity of paroxysmal dyskinesias. Brain. 2015 Dec;138(Pt 12):3567-80. doi
Tao T, Wang X, Liu M, Liu X. Myofibrillogenesis regulator-1 attenuates hypoxia/reoxygenation-induced injury by repairing microfilaments in neonatal rat cardiomyocytes. Exp Cell Res. 2015 Oct 1;337(2):234-42. doi: 10.1016/j.yexcr.2015.05.026. Epub 2015 Jun 4. PubMed
Lee J, Wong SA, Li BU, Boles RG. NextGen nuclear DNA sequencing in cyclic vomiting syndrome reveals a significant association with the stress-induced calcium channel (RYR2). Neurogastroenterol Motil. 2015 Jul;27(7):990-6. doi: 10.1111/nmo.12575. Epub 2015 Apr 29. PubMed
Mink JW. Treatment of paroxysmal dyskinesias in children. Curr Treat Options Neurol. 2015 Jun;17(6):350. doi
Shen Y, Ge WP, Li Y, Hirano A, Lee HY, Rohlmann A, Missler M, Tsien RW, Jan LY, Fu YH, Ptáček LJ. Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis. Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):2935-41. doi
Sadegh MK, Ekman M, Krawczyk K, Svensson D, Gransson O, Dahan D, Nilsson BO, Albinsson S, Uvelius B, Swrd K. Detrusor induction of miR-132/212 following bladder outlet obstruction
Tao TQ, Wang XR, Liu M, Xu FF, Liu XH. Myofibrillogenesis regulator-1 attenuated hypoxia/reoxygenation-induced apoptosis by inhibiting the PERK/Nrf2 pathway in neonatal rat cardiomyocytes. Apoptosis. 2015 Mar;20(3):285-97. doi: 10.1007/s10495-014-1081-1. PubMed
Wu L, Tang HD, Huang XJ, Zheng L, Liu XL, Wang T, Wang JY, Cao L, Chen SD. PRRT2 truncated mutations lead to nonsense-mediated mRNA decay in Paroxysmal Kinesigenic Dyskinesia. Parkinsonism Relat Disord. 2014 Dec;20(12):1399-404. doi: 10.1016/j.parkreldis.2014.10.012. Epub 2014 Oct 19. PubMed
Ghezzi D, Canavese C, Kovacevic G, Zamurovic D, Barzaghi C, Giorgi C, Zorzi G, Zeviani M, Pinton P, Garavaglia B, Nardocci N. A family with paroxysmal nonkinesigenic dyskinesias (PNKD)
Durinck S, Stawiski EW, Pava-Jimnez A, Modrusan Z, Kapur P, Jaiswal BS, Zhang N, Toffessi-Tcheuyap V, Nguyen TT, Pahuja KB, Chen YJ, Saleem S, Chaudhuri S, Heldens S, Jackson M, Pea-Llopis S, Guillory J, Toy K, Ha C, Harris CJ, Holloman E, Hill HM, Stinson J, Rivers CS, Janakiraman V, Wang W, Kinch LN, Grishin NV, Haverty PM, Chow B, Gehring JS, Reeder J, Pau G, Wu TD, Margulis V, Lotan Y, Sagalowsky A, Pedrosa I, de Sauvage FJ, Brugarolas J, Seshagiri S. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet. 2015 Jan;47(1):13-21. doi
van Coller R, Slabbert P, Vaidyanathan J, Schutte C. Successful treatment of disabling paroxysmal nonkinesigenic dyskinesia with deep brain stimulation of the globus pallidus internus. Stereotact Funct Neurosurg. 2014;92(6):388-92. doi: 10.1159/000365226. Epub 2014 Oct 28. PubMed
Liang S, Yu X, Zhang S, Tai J. A case of familial paroxysmal nonkinesigenic dyskinesia due to mutation of the PNKD gene in Chinese Mainland. Brain Res. 2015 Jan 21;1595:120-6. doi
Gong Y, He H, Liu H, Zhang C, Zhao W, Shao RG. Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells. FEBS Lett. 2014 Aug 25;588(17):2903-10. doi
Erro R, Sheerin UM, Bhatia KP. Paroxysmal dyskinesias revisited
Wang X, Tao T, Ding R, Song D, Liu M, Xie Y, Liu X. Kidney protection against ischemia/reperfusion injury by myofibrillogenesis regulator-1. Am J Nephrol. 2014;39(4):279-87. doi
Rana AQ, Nadeem A, Yousuf MS, Kachhvi ZM. Late onset of atypical paroxysmal non-kinesigenic dyskinesia with remote history of Graves' disease. J Neurosci Rural Pract. 2013 Oct;4(4):449-50. doi
Fekete R. Paroxysmal nonkinesigenic dyskinesia with tremor. Case Rep Neurol Med. 2013;2013:927587. doi
Morgante F, Klein C. Dystonia. Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1225-41. doi
Ganos C, Aguirregomozcorta M, Batla A, Stamelou M, Schwingenschuh P, Mnchau A, Edwards MJ, Bhatia KP. Psychogenic paroxysmal movement disorders--clinical features and diagnostic clues. Parkinsonism Relat Disord. 2014 Jan;20(1):41-6. doi
Wang JL, Mao X, Hu ZM, Li JD, Li N, Guo JF, Jiang H, Shen L, Li J, Shi YT, Xia K, Liu JY, Liao WP, Tang BS. Mutation analysis of PRRT2 in two Chinese BFIS families and nomenclature of PRRT2 related paroxysmal diseases. Neurosci Lett. 2013 Sep 27;552:40-5. doi
Zhao CY, Guo ZJ, Dai SM, Zhang Y, Zhou JJ. Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma. Tumour Biol. 2013 Oct;34(5):2983-7. doi: 10.1007/s13277-013-0862-4. Epub 2013 May 22. PubMed
Guo J, Dong B, Ji JF, Wu AW. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients. World J Gastroenterol. 2012 Oct 14;18(38):5434-41. doi
Yeh TH, Lin JJ, Lai SC, Wu-Chou YH, Chen AC, Yueh KC, Chen RS, Lu CS. Familial paroxysmal nonkinesigenic dyskinesia
Wang K, Zhao X, Du Y, He F, Peng G, Luo B. Phenotypic overlap among paroxysmal dyskinesia subtypes
Lu RQ, Sun M, Gao X, Guo L. [Expression of a novel biomarker, MR-1S, in ovarian carcinoma and its biological significance]. Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):176-81. doi
Wang X, Liu X, Wang S, Luan K. Myofibrillogenesis regulator 1 induces hypertrophy by promoting sarcomere organization in neonatal rat cardiomyocytes. Hypertens Res. 2012 Jun;35(6):597-603. doi
Lee HY, Nakayama J, Xu Y, Fan X, Karouani M, Shen Y, Pothos EN, Hess EJ, Fu YH, Edwards RH, Ptcek LJ. Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia. J Clin Invest. 2012 Feb;122(2):507-18. doi: 10.1172/JCI58470. Epub 2012 Jan 3. PubMed
Liu Q, Qi Z, Wan XH, Li JY, Shi L, Lu Q, Zhou XQ, Qiao L, Wu LW, Liu XQ, Yang W, Liu Y, Cui LY, Zhang X. Mutations in PRRT2 result in paroxysmal dyskinesias with marked variability in clinical expression. J Med Genet. 2012 Feb;49(2):79-82. doi
Newman JR, Sutherland GT, Boyle RS, Limberg N, Blum S, O'Sullivan JD, Silburn PA, Mellick GD. Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias. Parkinsonism Relat Disord. 2012 May;18(4):351-7. doi
Pons R, Cuenca-Len E, Miravet E, Pons M, Xaidara A, Youroukos S, Macaya A. Paroxysmal non-kinesigenic dyskinesia due to a PNKD recurrent mutation
Lu R, Sun M, Feng J, Gao X, Guo L. Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer. BMC Cancer. 2011 Jun 25;11:270. doi
Bhatia KP. Paroxysmal dyskinesias. Mov Disord. 2011 May;26(6):1157-65. doi: 10.1002/mds.23765. Review. PubMed
Shimojima K, Okumura A, Natsume J, Aiba K, Kurahashi H, Kubota T, Yokochi K, Yamamoto T. Spinocerebellar ataxias type 27 derived from a disruption of the fibroblast growth factor 14 gene with mimicking phenotype of paroxysmal non-kinesigenic dyskinesia. Brain Dev. 2012 Mar;34(3):230-3. doi: 10.1016/j.braindev.2011.04.014. Epub 2011 May 19. PubMed
Sohn YH, Lee PH. Paroxysmal choreodystonic disorders. Handb Clin Neurol. 2011;100:367-73. doi
Shen Y, Lee HY, Rawson J, Ojha S, Babbitt P, Fu YH, Ptcek LJ. Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability. Hum Mol Genet. 2011 Jun 15;20(12):2322-32. doi
Yang J, Krishnamoorthy G, Saxena A, Zhang G, Shi J, Yang H, Delaloye K, Sept D, Cui J. An epilepsy/dyskinesia-associated mutation enhances BK channel activation by potentiating Ca2+ sensing. Neuron. 2010 Jun 24;66(6):871-83. doi: 10.1016/j.neuron.2010.05.009. PubMed
Wang XR, Liu XH. [Research progress of myofibrillogenesis regulator 1]. Sheng Li Ke Xue Jin Zhan. 2009 Jul;40(3):245-8. Review. Chinese. PubMed
Norlinah MI, Shahizon AM. Paroxysmal dyskinesia as an unusual and only presentation of subcortical white matter ischaemia
Szczałuba K, Jurek M, Szczepanik E, Friedman A, Milewski M, Bal J, Mazurczak T. A family with paroxysmal nonkinesigenic dyskinesia
Mehta SH, Morgan JC, Sethi KD. Paroxysmal dyskinesias. Curr Treat Options Neurol. 2009 May;11(3):170-8. PubMed
Ghezzi D, Viscomi C, Ferlini A, Gualandi F, Mereghetti P, DeGrandis D, Zeviani M. Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. Hum Mol Genet. 2009 Mar 15;18(6):1058-64. doi
Friedman A, Zakrzewska-Pniewska B, Domitrz I, Lee HY, Ptacek L, Kwiecinski H. Paroxysmal non-kinesigenic dyskinesia caused by the mutation of MR-1 in a large Polish kindred. Eur Neurol. 2009;61(1):39-41. doi
Ren K, Jin H, Bian C, He H, Liu X, Zhang S, Wang Y, Shao RG. MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway. J Biol Chem. 2008 Dec 19;283(51):35598-605. doi
Unterberger I, Trinka E. Diagnosis and treatment of paroxysmal dyskinesias revisited. Ther Adv Neurol Disord. 2008 Sep;1(2):4-11. doi: 10.1177/1756285608095119. PubMed
Mink JW. Paroxysmal dyskinesias. Curr Opin Pediatr. 2007 Dec;19(6):652-6. Review. PubMed
Pasquariello A, Innocenti M, Batini V, Pasquariello G, Beati S, Rindi S, Paoletti S, Panichi V. Theoretical calculation of optimal depth in the percutaneous native kidney biopsy to drastically reduce bleeding complications and sample inadequacy for histopathological diagnosis. Nephrol Dial Transplant. 2007 Dec;22(12):3516-20. Epub 2007 Sep 21. PubMed
Bruno MK, Lee HY, Auburger GW, Friedman A, Nielsen JE, Lang AE, Bertini E, Van Bogaert P, Averyanov Y, Hallett M, Gwinn-Hardy K, Sorenson B, Pandolfo M, Kwiecinski H, Servidei S, Fu YH, Ptcek L. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology. 2007 May 22;68(21):1782-9. PubMed
Li HL, She ZG, Li TB, Wang AB, Yang Q, Wei YS, Wang YG, Liu DP. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice. Hypertension. 2007 Jun;49(6):1399-408. Epub 2007 Apr 9. Erratum in
Bergmann MW, De Windt LJ. Linking cardiac mechanosensing at the sarcomere M-band, nuclear factor kappaB signaling, and cardiac remodeling. Hypertension. 2007 Jun;49(6):1225-7. Epub 2007 Apr 2. PubMed
Hall DA, Parsons J, Benke T. Paroxysmal nonkinesigenic dystonia and celiac disease. Mov Disord. 2007 Apr 15;22(5):708-10. PubMed
Stefanova E, Djarmati A, Momcilović D, Dragasević N, Svetel M, Klein C, Kostić VS. Clinical characteristics of paroxysmal nonkinesigenic dyskinesia in Serbian family with Myofibrillogenesis regulator 1 gene mutation. Mov Disord. 2006 Nov;21(11):2010-5. PubMed
Spacey SD, Adams PJ, Lam PC, Materek LA, Stoessl AJ, Snutch TP, Hsiung GY. Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia. Neurology. 2006 May 23;66(10):1588-90. PubMed
Hempelmann A, Kumar S, Muralitharan S, Sander T. Myofibrillogenesis regulator 1 gene (MR-1) mutation in an Omani family with paroxysmal nonkinesigenic dyskinesia. Neurosci Lett. 2006 Jul 10;402(1-2):118-20. Epub 2006 Apr 24. PubMed
Djarmati A, Svetel M, Momcilovic D, Kostic V, Klein C. Significance of recurrent mutations in the myofibrillogenesis regulator 1 gene. Arch Neurol. 2005 Oct;62(10):1641. PubMed
Li TB, Hu Y, Wang YG, Xia HZ. [Cloning of mMR-1 gene and expression in Pichia pastoris systems]. Sheng Wu Gong Cheng Xue Bao. 2005 Jan;21(1):25-9. Chinese. PubMed
Chen DH, Matsushita M, Rainier S, Meaney B, Tisch L, Feleke A, Wolff J, Lipe H, Fink J, Bird TD, Raskind WH. Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds. Arch Neurol. 2005 Apr;62(4):597-600. PubMed PMID: 15824259.
Li TB, Hu Y, Feng S, Zuo ZY, Wang YG. [Expression of a human myofibrillogenesis regulator 1 gene in E. coli and its immunogenicity]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):42-7. Chinese. PubMed
Lee HY, Xu Y, Huang Y, Ahn AH, Auburger GW, Pandolfo M, Kwiecinski H, Grimes DA, Lang AE, Nielsen JE, Averyanov Y, Servidei S, Friedman A, Van Bogaert P, Abramowicz MJ, Bruno MK, Sorensen BF, Tang L, Fu YH, Ptcek LJ. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet. 2004 Dec 15;13(24):3161-70. Epub 2004 Oct 20. PubMed
Li TB, Liu XH, Feng S, Hu Y, Yang WX, Han Y, Wang YG, Gong LM. Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle. Acta Biochim Biophys Sin (Shanghai). 2004 Jun;36(6):412-8. PubMed
Gonzalez-Alegre P, Ammache Z, Davis PH, Rodnitzky RL. Moyamoya-induced paroxysmal dyskinesia. Mov Disord. 2003 Sep;18(9):1051-6. PubMed
Cuenca-Leon E, Cormand B, Thomson T, Macaya A. Paroxysmal kinesigenic dyskinesia and generalized seizures
Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord. 2002 Jul;17(4):726-34. PubMed
Bhatia KP. Familial (idiopathic) paroxysmal dyskinesias
Loher TJ, Krauss JK, Burgunder JM, Taub E, Siegfried J. Chronic thalamic stimulation for treatment of dystonic paroxysmal nonkinesigenic dyskinesia. Neurology. 2001 Jan 23;56(2):268-70. PubMed
Lombroso CT, Fischman A. Paroxysmal non-kinesigenic dyskinesia: pathophysiological investigations. Epileptic Disord. 1999 Sep;1(3):187-93. PubMed
Mnchau A, Valente EM, Shahidi GA, Eunson LH, Hanna MG, Quinn NP, Schapira AH, Wood NW, Bhatia KP. A new family with paroxysmal exercise induced dystonia and migraine
del Carmen Garca M, Intruvini S, Vazquez S, Beserra F, Rabinowicz AL. Ictal SPECT in paroxysmal non-kinesigenic dyskinesia. Case report and review of the literature. Parkinsonism Relat Disord. 2000 Apr 1;6(2):119-121. PubMed PMID: 10699395.
Bhatia KP. The paroxysmal dyskinesias. J Neurol. 1999 Mar;246(3):149-55. Review. PubMed
Demirkiran M, Jankovic J. Paroxysmal dyskinesias


Home cDNA Library DeepCAGE Service Clone Distribution

Powered by Japan Bioinformatics K.K.